Search - tctmd.com

Displaying 801 - 820 of 2963

Sort: Relevancy | Date

Presentation TCT 2017

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Presenter: Julinda Mehilli, Giulio G. Stefanini, Dariusz Dudek

October 30, 2017

Presentation TCT 2017

Emerging Thromboresistant BMS 2: Titanium-Nitride-Oxide Stents

Presenter: Julinda Mehilli, Giulio G. Stefanini, Pim A.L. Tonino

October 30, 2017

Presentation TCT 2017

Emerging Thromboresistant BMS 1: Cobra PzF Stents

Presenter: Julinda Mehilli, Giulio G. Stefanini, Donald Cutlip

October 30, 2017

Presentation TCT 2017

Should BMS Stay On the Shelf? Clinical and Global Perspectives on the Role Of BMS in 2017

Presenter: Julinda Mehilli, Giulio G. Stefanini, Raffaele Piccolo

October 30, 2017

Presentation TCT 2017

Case #4: Central Venous Stents: When, Which, and How (With Discussion)

Presenter: Mahmood K. Razavi

October 30, 2017

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

Presentation TCT 2017

Novel Technique: Use of Mother in Child Guideliner Catheter as a Conduit for Optimal Visualization and Deployment of Stents in Coronary Ostial Lesions

Presenter: Peter L Duffy, Yuejin Yang, Harinder K Bali

October 30, 2017

Presentation TCT 2017

Iliac Vein Compression: Indications and Techniques for Venous Stents (Case Reviews)

Presenter: Michael R. Jaff, Robert A. Lookstein, Sanjiv Lakhanpal

October 30, 2017

News Daily News

Lesion Complexity and Patient Risk: A Balancing Act for DAPT Duration

Yael L. Maxwell

October 23, 2017

News Daily News

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Yael L. Maxwell

October 20, 2017

News Daily News

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Michael O'Riordan

October 17, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

News Featured Fellow

Felipe Albuquerque, MD

Yael L. Maxwell

September 28, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

Presentation ESC 2017

BIOFLOW V Comparison of Ultrathin Sirolimus-Eluting Bioresorbable Polymer with Thin Everolimus-Eluting Durable Polymer Stents

Presenter: David E Kandzari

September 13, 2017

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Opinion Editor's Corner

Q&A: Juan Granada Takes the Helm at the Cardiovascular Research Foundation

Shelley Wood

September 12, 2017

News Opinion Editor's Corner ESC 2017

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

Shelley Wood

September 08, 2017

Advertisement

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Emerging Thromboresistant BMS 2: Titanium-Nitride-Oxide Stents

Emerging Thromboresistant BMS 1: Cobra PzF Stents

Should BMS Stay On the Shelf? Clinical and Global Perspectives on the Role Of BMS in 2017

Case #4: Central Venous Stents: When, Which, and How (With Discussion)

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Novel Technique: Use of Mother in Child Guideliner Catheter as a Conduit for Optimal Visualization and Deployment of Stents in Coronary Ostial Lesions

Iliac Vein Compression: Indications and Techniques for Venous Stents (Case Reviews)

Lesion Complexity and Patient Risk: A Balancing Act for DAPT Duration

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Generic ARBs Linked to Increased Adverse Events

Felipe Albuquerque, MD

New Performance and Quality Metrics for STEMI and NSTEMI Care

BIOFLOW V Comparison of Ultrathin Sirolimus-Eluting Bioresorbable Polymer with Thin Everolimus-Eluting Durable Polymer Stents

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Q&A: Juan Granada Takes the Helm at the Cardiovascular Research Foundation

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content